Imagine three dominoes falling in a row — each one knocking over the next without any help from you. That's essentially what chemists at the University of Münster in Germany have figured out how to do with molecules. A team led by Professor Frank Glorius has created a new chemical process where one reaction automatically sets off the next two, all inside a single test tube, powered by nothing more than ordinary visible light.
The discovery, published in the journal Nature Catalysis, could make it much easier and cheaper to build the complex three-dimensional molecules that show up inside many modern medicines.
"Such one-pot synthesis is considered an ideal process because it is particularly resource- and energy-efficient," the researchers explained.
Here's how it works. The team uses a special molecule called a photocatalyst — a tiny helper that soaks up visible light and passes that energy along to the chemical reactions happening around it. In the first step, two simple molecules called bicyclic azaarenes and vinylcyclopropanes snap together to create a large, nine-membered ring structure. Normally, building such a ring requires harsh conditions and lots of heat. But here, something interesting happens in the second step: the atoms inside the newly formed molecule rearrange their connections all on their own, like pieces of furniture shuffling around a room. This rearrangement normally needs high temperatures, yet it happened at plain old room temperature thanks to the light energy flowing through the photocatalyst. In the third and final step, light triggers one more round of ring-building, locking the molecule into its final 3D shape.
The team, which included doctoral student Preeti Chahar and researcher Utpal Kundu, tested their method with various starting materials and found it worked reliably across different examples. Computer modeling and detailed lab tests helped them understand exactly how the reaction pathway unfolded.
"The design of triple catalysis expands the chemical toolset by introducing a new reaction protocol to construct complex architectures that have traditionally relied on 'harsh' reaction conditions," said Chahar.
The implications could stretch far beyond this single lab in Germany. Complex 3D molecular structures show up in many pharmaceutical active ingredients, and being able to build them more simply — with one reaction vessel instead of many, and at room temperature instead of high heat — could eventually mean fewer resources, less energy, and lower costs for drug development. It's the kind of quiet breakthrough that might not make headlines, but could quietly change how new medicines get made.